Modulation of TGF-.beta. by recombinant TGF-.beta. type II receptor polypeptides
US6046157A · kind A · utility
12Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 1995 |
| Grant date | Apr 4, 2000 |
| Priority date | — |
| Expiry date | May 23, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The mammalian TGF-.beta. type II receptor has been cloned. Recombinant TGF-.beta.-binding receptor polypeptides are useful to alter the binding of TGF-.beta. to its receptors and to modulate the effects of TGF-.beta. in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.